LXRX — LEXICON PHARMACEUTICALS, INC.

—
Nasdaq · Health Care · Pharmaceuticals · CIK 1062822 ·
Last close
$1.78
Market Cap
$792.52M
52W High
$2.68
52W Low
$1.10
ADV30
2,109,137
Next earnings
2026-11-05

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 — — — — — — —
Jun 2026 692,000 653,000 -26,540,000 -31,775,000 250,060,000 40,924,000 75,535,000
Mar 2026 21,102,000 20,994,000 -996,000 -1,043,000 268,819,000 38,089,000 65,963,000
Dec 2025 5,493,000 5,292,000 -14,780,000 -15,530,000 184,987,000 34,326,000 77,449,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-64,988,000
Investing CF
$-29,769,000
Financing CF
$85,317,000
CapEx
—
Dividends Paid
—
Buybacks
$0
EPS Diluted TTM
$-0.14
As of
2026-11-08

Balance + Analyst (yfinance extras)

Retained Earnings
$-2,050,401,000
Inventory
$1,196,000
Receivables
$1,643,000
ST Investments
$149,686,000
EBIT TTM
$-52,732,000
Pretax Income TTM
$-61,117,000
Interest Exp TTM
$8,385,000
Analysts
6

Yahoo Snapshot (yfinance, live)

Total Revenue
$41,469,000
EBITDA
$-54,023,000
Free Cash Flow
$-44,774,624
Enterprise Value
$527,165,792
Total Cash
$190,610,000
Total Debt
$59,241,000
Shares Out
445,234,571
Trailing EPS
$-0.15
Book Value
$0.30
ROE
-40.2%
ROA
-14.3%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 5y)

Revenues vs Net Income (last 5y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 49,803,000 -48,911,000 -50,341,000 184,987,000 77,449,000 107,538,000 -67,851,000
Dec 2024 31,081,000 -197,117,000 -200,403,000 298,420,000 152,470,000 145,950,000 -178,780,000
Dec 2023 1,204,000 -171,750,000 -177,119,000 229,429,000 136,319,000 93,110,000 -161,897,000
Dec 2022 139,000 -100,760,000 -101,944,000 194,299,000 77,175,000 117,124,000 -88,851,000
Dec 2021 — — — — — — —

TTM Snapshot

Revenues TTM
$41,469,000
NetIncome TTM
$-61,116,000
OpCashFlow TTM
—
Assets (Latest)
$250,060,000
Forward EPS
$-0.19

Max Pain — expiry 2027-01-15

max pain strike: $1.00 · spot: $1.71 · call oi: 12,260 · put oi: 875
Expected Move to 2027-01-15: ±$0.57 (33.63%) — implied range $1.14 – $2.29 · ATM straddle on $1.50 strike

Peers — same industry

TickerNameMarket CapLastDaily %
COLL COLLEGIUM PHARMACEUTICAL, INC $793.98M $25.55 —
ARDX ARDELYX, INC. $799.36M $3.18 —
IRWD IRONWOOD PHARMACEUTICALS INC $806.23M $4.87 —
RIGL RIGEL PHARMACEUTICALS INC $808.18M $42.92 —
IVA Inventiva S.A. $760.63M $3.22 —

News headlines (Yahoo Finance, 1h cache)

Lexicon Pharmaceuticals to Present at the Jefferies Global Healthcare Conference in London
2026-11-11 13:30 · Yahoo
New Data at 2026 American Heart Association Scientific Sessions Highlight Cardiovascular Effects of Sotagliflozin on Thrombus Formation and in Hypertrophic Cardiomyopathy
2026-11-09 13:30 · Yahoo
What Lexicon Pharmaceuticals (LXRX) Said on Its Q3 Earnings Call
2026-11-06 09:14 · Yahoo
Lexicon (LXRX) Q3 2026 Earnings Call Transcript
2026-11-05 19:16 · Yahoo
Lexicon Pharmaceuticals (LXRX) Reports Q3 Loss, Tops Revenue Estimates
2026-11-05 13:35 · Yahoo
Lexicon: Q3 Earnings Snapshot
2026-11-05 12:22 · Yahoo
Lexicon Pharmaceuticals Reports Third Quarter 2026 Financial Results and Provides Clinical Updates
2026-11-05 12:00 · Yahoo
Lexicon Pharmaceuticals to Report Third Quarter 2026 Financial Results on November 5, 2026
2026-10-29 12:30 · Yahoo
Lexicon Pharmaceuticals Provides Update on Baseline Patient Characteristics for Pivotal Phase 3 SONATA-HCM Study of Sotagliflozin in Symptomatic Hypertrophic Cardiomyopathy
2026-10-23 12:30 · Yahoo
Why Lexicon Pharmaceuticals Stock Popped by Almost 6% Today
2026-09-28 21:25 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.